Search results
FIFA defaults Equatorial Guinea's World Cup qualifying wins over same ineligible player as in 2013
Stamford Advocate· 2 days agoFor the second time, Equatorial Guinea must forfeit two World Cup qualifying games for fielding star...
Australian researchers reveal function of vaccine-boosting molecule; unlocks pathways for next-gen...
Investing.com· 5 days agoAustralian researchers have unlocked the mechanism of a key vaccine-boosting component, gaining new...
mRNA Vaccines vs. the Pandemic
The North Coast Journal· 4 days ago"I knew that [mRNA] can be used for everything and I had a kind of a Cassandra feeling, that I can see the future and nobody believes me." About 13...
Congo: Traps, Treaties And Counterterrorism
Strategy Page· 5 days agoDecember 30, 2021: In Congo investigators continue to probe the so-called “China deal” which was meant to trade Congo minerals for infrastructure projects built by China. China is – or was—supposed ...
WHO Ethiopia hosts Regional workshop on Preventing and Responding to Sexual Exploitation, Abuse, and...
World Health Organization· 5 days agoAddis Ababa, Ethiopia—The WHO Africa Regional Office (WHO AFRO) in collaboration with WHO Headquarters and WHO Ethiopia, hosted the first regional workshop on preventing and responding to sexual ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 days agoOttawa, May 24, 2024 (GLOBE NEWSWIRE) -- The global viral vectors & plasmid DNA manufacturing market size is estimated to grow from USD 5.4 billion in 2023 to USD 20.44 billion by 2032, According to Precedence Research. The viral vectors & plasmid
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
WKRN Nashville· 3 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
KTLA-TV Los Angeles· 4 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
